Europe Equine Healthcare Market Share is projected to witness growth at a CAGR of 6.3% during the forecast period

According to an exhaustive report by Polaris Market Research, the global Europe equine healthcare market is poised for significant growth over the next decade. 𝐈𝐧 𝟐𝟎𝟐𝟑, 𝐠𝐥𝐨𝐛𝐚𝐥 𝐬𝐚𝐥𝐞𝐬 𝐢𝐧𝐜𝐨𝐦𝐞 𝐫𝐞𝐚𝐜𝐡𝐞𝐝 𝐔𝐒𝐃 𝟏,𝟏𝟐𝟖.𝟕𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧. 𝐏𝐫𝐞𝐝𝐢𝐜𝐭𝐞𝐝 𝐭𝐨 𝐛𝐨𝐨𝐬𝐭 𝐚𝐭 𝐚 𝐫𝐨𝐛𝐮𝐬𝐭 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟑%, 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏,𝟗𝟓𝟗.𝟒𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/europe-equine-healthcare-market/request-for-sample

Communicable illnesses are those that can proliferate from one animal to another. Regulatory programs should be aimed at decreasing openness to illness-causing agents and escalating illness aversion. To decrease communicable illnesses openness to resident horses it should be needed that contemporary horses have a negative test for Equine Infectious Anemia and have been properly vaccinated a dewormed prior to their arrival.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬
• The market for Europe equine healthcare is expanding due to escalated illness prevalence with a concentration on preventive care.
• European governments frequently execute and administer strict animal welfare directives. These calibers instruct systematic veterinary assessment, vaccinations, and prohibitive care to sanction the health and well-being of the horses. For instance, the European Commission instigated EUNetHorse, the Horizon Europe strategy for equine animals. This project intends to interchange knowledge and assimilation between actors and stakeholders of the equine sector to enhance equine animals' well-being. Conformity with such directives escalates the demand for equine healthcare services.
• The appearance of contemporary players in the market generates an aggressive environment amidst contemporary and prevailing market contenders. This contention causes enhanced and progressive services, superior pricing, and more alternatives for horse owners. Coho, a France-established startup, advanced a distinct application that traces and observes horses when in a stable. The initiation of contemporary cure alternatives by startups drives the Europe equine healthcare market growth.

𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐏𝐫𝐨𝐟𝐢𝐥𝐞
Significant market contenders are funding massively in research and development to augment their offerings which will assist the market to grow even more.

Major companies in the Europe equine healthcare market are noted below:
• Zoetis Services LLC
• Boehringer Ingelheim International GmbH
• Arthrex Inc.
• Dechra
• Ceva Sante Animale
• Merck & Co., Inc.
• Heska Corporation
• Hallmarq Veterinary Imaging
• ESAOTE SPA
• Vetoquinol S.A.
• IDEXX Laboratories, Inc.
• Elanco
• Covetrus Inc.
• Cargill
• Biosig Instruments Inc.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/europe-equine-healthcare-market/request-for-discount-pricing

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐦𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗-𝟐𝟎𝟑𝟐)
• Vaccines
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory & Analgesics
o Other Pharmaceuticals
• Medicinal Feed Additives
• Orthobiologics
• Diagnostics
o Diagnostic Test Kits
o Diagnostic Equipment
• Software
o Practice Management Software
o Imaging Software
o Telehealth Software
o Other Software
• Other

𝐁𝐲 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐦𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗-𝟐𝟎𝟑𝟐)
• Musculoskeletal Disorders
• Parasitic Infections
• Equine Herpes Virus
• Equine Viral Arteritis (EVA)
• Equine Influenza
• West Nile Virus
• Tetanus
• Other

𝐁𝐲 𝐀𝐜𝐭𝐢𝐯𝐢𝐭𝐲 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐦𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗-𝟐𝟎𝟑𝟐)
• Sports/Racing
• Recreation
• Other

𝐁𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞, 𝐔𝐒𝐃 𝐦𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗-𝟐𝟎𝟑𝟐)
• Veterinary Hospitals & Clinics
• E-commerce
• Equestrian Facilities
• Other

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/europe-equine-healthcare-market

𝐄𝐮𝐫𝐨𝐩𝐞 𝐄𝐪𝐮𝐢𝐧𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• In terms of activity, the sports/racing segment accounted for the largest market share in 2023, owing to the growing popularity of equestrian sports and competitive racing across Europe.
• The recreation segment is expected to witness the highest growth during the forecast period, owing to the rise in recreational riding and leisure activities
• Based on product, the pharmaceuticals segment accounted for the largest market share in 2023, owing to the persistent demand for advanced treatments for common equine conditions such as respiratory infections and musculoskeletal issues.
• The software segment is projected to grow at a robust pace in the coming years because of the increasing integration of digital technologies in equine healthcare management.
• The UK accounted for a major market share in 2023. The market growth in the country is attributed to the growing emphasis on recreational riding and the increasing number of leisure horses. Furthermore, the increasing incidence of equine influenza, West Nile virus, and tetanus diseases among horses in the UK boosts the country's market growth.
• The market in Germany is projected to register the fastest growth during the forecast period, attributable to its well-established equestrian industry and robust healthcare infrastructure. Additionally, Germany's advanced veterinary research institutions and high standards of care contribute to its market growth.
• Zoetis Services LLC; Arthrex Inc.; Dechra; Ceva Sante Animale; Merck & Co., Inc.; Heska Corporation; Hallmarq Veterinary Imaging; ESAOTE SPA; Vetoquinol S.A.; IDEXX Laboratories, Inc.; Elanco; Covetrus Inc.; Cargill; and Biosig Instruments Inc. are among the European market players.

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
𝐂𝐞𝐥𝐥 𝐃𝐢𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market

𝐈𝐧𝐬𝐩𝐞𝐜𝐭𝐢𝐨𝐧 𝐌𝐚𝐜𝐡𝐢𝐧𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/inspection-machines-market

𝐒𝐲𝐧𝐭𝐡𝐞𝐭𝐢𝐜 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/synthetic-biology-market

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐄𝐱𝐜𝐢𝐩𝐢𝐞𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market

𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.polarismarketresearch.com/industry-analysis/drug-discovery-services-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
𝐋𝐢𝐤𝐡𝐢𝐥 𝐆
8 The Green Ste 19824,
Dover, DE 19901,
United States
𝐏𝐡𝐨𝐧𝐞: +1-929 297-9727
𝐄𝐦𝐚𝐢𝐥: sales@polarismarketresearch.com
𝐖𝐞𝐛: https://www.polarismarketresearch.com
𝐅𝐨𝐥𝐥𝐨𝐰 𝐔𝐬: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.